Bullish
H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy
H.C. Wainwright has reiterated a Buy rating and a $10.00 price target for Oncolytics Biotech (NASDAQ:ONCY) following a virtual fireside panel discussi...